Neuroregulatory Research Peptides

Selank is a tuftsin analogue studied for GABAergic and anxiolytic effects. DSIP is linked to sleep regulation, VIP to circadian and immune signalling, and Dermorphin to mu-opioid receptors.

Neuroregulatory research peptides Ireland: mood, sleep and signalling pathways

Neuroregulatory research peptides cover a deliberately broad set of pathways — mood, sleep, circadian and pain signalling — united by their action on central and peripheral neuropeptide systems rather than a single shared receptor. Selank, DSIP, VIP and Dermorphin each anchor a distinct mechanistic area within this collection.

For labs building a neuroregulatory research peptides Ireland protocol, the breadth of this group means compound choice should be driven entirely by the specific endpoint under study, since these four peptides do not share a common mode of action.

Distinct mechanisms across Selank, DSIP, VIP and Dermorphin

Selank is a synthetic analogue of the tuftsin peptide, studied for anxiolytic-type effects linked to GABAergic and enkephalin signalling. DSIP (delta sleep-inducing peptide) is studied for its proposed role in sleep architecture regulation, while VIP (vasoactive intestinal peptide) acts on circadian and immune signalling pathways.

Dermorphin is structurally distinct again, an amphibian-derived opioid peptide studied for its high affinity at mu-opioid receptors, making it a useful reference ligand in opioid receptor pharmacology research. Oxytocin is cross-linked into this collection as a comparator for broader neuroendocrine and social-behaviour signalling.

Laboratory applications across neuroregulatory pathways

Anxiety and stress-response models commonly use Selank, tracking behavioural and biochemical markers linked to GABAergic tone. Sleep architecture studies employ DSIP, typically using EEG-based or behavioural sleep-stage measures in rodent models.

VIP appears in circadian rhythm and immune-signalling research, while Dermorphin is used in opioid receptor binding and pain-signalling assays as a high-affinity reference compound against which other opioid-pathway peptides can be benchmarked.

Study design across a mechanistically diverse compound set

Because these four peptides act on unrelated systems, study design should treat each as an independent research line with its own validated assay rather than assuming shared dosing or sampling schedules will transfer between compounds.

Time-of-day is a particularly important variable for DSIP and VIP studies given their links to circadian biology, and researchers should record administration time precisely alongside behavioural or biochemical endpoints to avoid confounding results.

Handling, storage and batch verification for neuroregulatory peptides

All four compounds are supplied lyophilised and are most stable stored frozen or refrigerated before reconstitution; once reconstituted, solutions should be refrigerated and used promptly in line with standard peptide handling practice to avoid degradation affecting assay sensitivity.

As with the rest of the neuroregulatory research peptides Ireland range, Kensington Labs Ireland supplies a batch-specific certificate of analysis confirming HPLC purity and LC-MS verified identity for Selank, DSIP, VIP and Dermorphin, so research teams can verify each compound before starting a protocol.

Compound comparison

Research considerations

These compounds act on very different systems, so endpoint choice should be specific to each.